HIV-protease inhibitors block the enzymatic activity of purified Ste24p

Biochemical and Biophysical Research Communications

Volumn 374, Issue 2, 2008, Pages 365-368

  Hudon, Sarah E ^a   Coffinier, Catherine ^b   Michaelis, Susan ^c   Fong, Loren G ^b   Young, Stephen G ^b   Hrycyna, Christine A ^a  

^a PURDUE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HIV PI; Lamins; Lipodystrophy; Methyltransferase; Protease; Ste14p; Ste24p; ZMPSTE24

Indexed keywords

DARUNAVIR; INTEGRAL MEMBRANE METHYLTRANSFERASE STE24P; INTEGRAL MEMBRANE ZINC METALLOPROTEASE ZMPSTE24; LOPINAVIR; METALLOPROTEINASE; METHYLTRANSFERASE; PRELAMIN A; PROTEIN; RITONAVIR; TIPRANAVIR;

ARTICLE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PURIFICATION; LIPODYSTROPHY; PRIORITY JOURNAL; YEAST;

CATALYSIS; HIV PROTEASE INHIBITORS; HUMANS; MEMBRANE PROTEINS; METALLOENDOPEPTIDASES; NUCLEAR PROTEINS; PROTEIN METHYLTRANSFERASES; PROTEIN PRECURSORS; PYRIDINES; PYRIMIDINONES; PYRONES; RITONAVIR; SACCHAROMYCES CEREVISIAE PROTEINS;

MAMMALIA;

EID: 48349108128     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.07.033     Document Type: Article

References (26)

1. Clarke S. Protein isoprenylation and methylation at carboxyl-terminal cysteine residues. Annu. Rev. Biochem. 61 (1992) 355-386
2. Fujimura-Kamada K., Nouvet F.J., and Michaelis S. A novel membrane-associated metalloprotease, Ste24p, is required for the first step of NH2-terminal processing of the yeast a-factor precursor. J. Cell. Biol. 136 (1997) 271-285
3. Boyartchuk V.L., Ashby M.N., and Rine J. Modulation of ras and a-factor function by carboxyl-terminal proteolysis. Science 275 (1997) 1796-1800
4. Trueblood C.E., Boyartchuk V.L., Picologlou E.A., Rozema D., Poulter C.D., and Rine J. The CaaX proteases, Afc1p and Rce1p, have overlapping but distinct substrate specificities. Mol. Cell. Biol. 20 (2000) 4381-4392
5. Hrycyna C.A., Sapperstein S.K., Clarke S., and Michaelis S. The Saccharomyces cerevisiae STE14 gene encodes a methyltransferase that mediates C-terminal methylation of a-factor and RAS proteins. EMBO J. 10 (1991) 1699-1709
6. Hrycyna C.A., and Clarke S. Farnesyl cysteine C-terminal methyltransferase activity is dependent upon the STE14 gene product in Saccharomyces cerevisiae. Mol. Cell. Biol. 10 (1990) 5071-5076
7. Adames N., Blundell K., Ashby M.N., and Boone C. Role of yeast insulin-degrading enzyme homologs in propheromone processing and bud site selection. Science 270 (1995) 464-467
8. Schmidt W.K., Tam A., and Michaelis S. Reconstitution of the Ste24p-dependent N-terminal proteolytic step in yeast a-factor biogenesis. J. Biol. Chem. 275 (2000) 6227-6233
9. Corrigan D.P., Kuszczak D., Rusinol A.E., Thewke D.P., Hrycyna C.A., Michaelis S., and Sinensky M.S. Prelamin A endoproteolytic processing in vitro by recombinant ZMPSTE24. Biochem. J. 387 (2005) 129-138
10. Leung G.K., Schmidt W.K., Bergo M.O., Gavino B., Wong D.H., Tam A., Ashby M.N., Michaelis S., and Young S.G. Biochemical studies of ZMPSTE24-deficient mice. J. Biol. Chem. 276 (2001) 29051-29058
11. Agarwal A.K., Fryns J.P., Auchus R.J., and Garg A. Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia. Hum. Mol. Genet. 12 (2003) 1995-2001
12. Tam A., Nouvet F.J., Fujimura-Kamada K., Slunt H., Sisodia S.S., and Michaelis S. Dual roles for Ste24p in yeast a-factor maturation: NH2-terminal proteolysis and COOH-terminal CaaS processing. J. Cell. Biol. 142 (1998) 635-649
13. Agarwal A.K., and Garg A. Genetic basis of lipodystrophies and management of metabolic complications. Annu. Rev. Med. 57 (2006) 297-311
14. Chen D., Misra A., and Garg A. Clinical review 153: lipodystrophy in human immunodeficiency virus-infected patients. J. Clin. Endocrinol. Metab. 87 (2002) 4845-4856
15. Caron M., Auclair M., Sterlingot H., Kornprobst M., and Capeau J. Some HIV protease inhibitors alter lamin A/C maturation and stability, Srebp-1 nuclear localization and adipocyte differentiation. AIDS 17 (2003) 2437-2444
16. Coffinier C., Hudon S.E., Farber E.A., Chang S.Y., Hrycyna C.A., Young S.G., and Fong L.G. HIV protease inhibitors block the zinc metalloproteinase ZMPSTE24 and lead to an accumulation of prelamin A in cells. Proc. Natl. Acad. Sci. USA 104 (2007) 13432-13437
17. Coffinier C., Hudon S.E., Lee R., Farber E.A., Nobumori C., Miner J.H., Andres D.A., Spielmann H.P., Hrycyna C.A., Fong L.G., and Young S.G. A potent HIV protease inhibitor, darunavir, does not inhibit ZMPSTE24 or lead to an accumulation of farnesyl-prelamin A in cells. J. Biol. Chem. 283 (2008) 9797-9804
18. Anderson J.L., Frase H., Michaelis S., and Hrycyna C.A. Purification, functional reconstitution, and characterization of the Saccharomyces cerevisiae isoprenylcysteine carboxylmethyltransferase Ste14p. J. Biol. Chem. 280 (2005) 7336-7345
19. 2-terminal processing of the yeast a-factor precursor. J. Biol. Chem. 276 (2001) 46798-46806
20. Schaffner W., and Weissmann C. A rapid, sensitive, and specific method for the determination of protein in dilute solution. Anal. Biochem. 56 (1973) 502-514
21. Hrycyna C.A., Wait S.J., Backlund Jr. P.S., and Michaelis S. Yeast ste14 methyltransferase, expressed as trpe-ste14 fusion protein in Escherichia coli, for in vitro carboxylmethylation of prenylated polypeptides. Methods Enzymol. 250 (1995) 251-266
22. Ota I.M., and Clarke S. Enzymatic methylation of 23-29-kda bovine retinal rod outer segment membrane proteins. Evidence for methyl ester formation at carboxyl-terminal cysteinyl residues. J. Biol. Chem. 264 (1989) 12879-12884
23. Miyoshi Y., Akagi M., Agarwal A.K., Namba N., Kato-Nishimura K., Mohri I., Yamagata M., Nakajima S., Mushiake S., Shima M., Auchus R.J., Taniike M., Garg A., and Ozono K. Severe mandibuloacral dysplasia caused by novel compound heterozygous ZMPSTE24 mutations in two Japanese siblings. Clin. Genet. 73 (2008) 535-544
24. Shackleton S., Smallwood D.T., Clayton P., Wilson L.C., Agarwal A.K., Garg A., and Trembath R.C. Compound heterozygous ZMPSTE24 mutations reduce prelamin A processing and result in a severe progeroid phenotype. J. Med. Genet. 42 (2005) e36
25. Carr A., Samaras K., Burton S., Law M., Freund J., Chisholm D.J., and Cooper D.A. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 12 (1998) F51-F58
26. Romano J.D., Schmidt W.K., and Michaelis S. The Saccharomyces cerevisiae prenylcysteine carboxyl methyltransferase Ste14p is in the endoplasmic reticulum membrane. Mol. Biol. Cell 9 (1998) 2231-2247